Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel

Abstract

With the development of new cancer therapies, systemic toxicity profile and effects on survival achieved an important improvement. However, a constellation of toxicities has emerged, even more remarkably, cutaneous adverse events. This report, developed by a board of Brazilian experts in oncodermatology, aims to establish a guideline for the dermatological care of oncologic patients. When possible, evidence-based recommendations were made, but in many cases, when strong evidence was not available, a consensus was reached, based on some data supporting therapies combined with personal experiences.

Keywords: Antineoplastic agents; Antineoplastic agents, immunological; Dermatology; Drug-related side effects and adverse reactions; Medical oncology; Molecular targeted therapy.